Braun J, Baraliakos X, Deodhar AA, et al. Secukinumab Demonstrates Low Radiographic Progression and Sustained Efficacy through 4 Years in Patients with Active Ankylosing Spondylitis. ACR 2017, abstract 3L.
Associatie tussen auto-immuunziekte en MGUS?
jul 2024 | RA, Sjögren